Aplio i900 vs AT-Patch (ATP-C130/ATP-C70)

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Canon Medical Systems Corporation
VS
by ATsens Co.

AI Verdict

These tools are adjacent rather than direct competitors, as they address different aspects of cardiac diagnostics. The Aplio i900 is a premium ultrasound system for real-time, detailed cardiovascular imaging and structural analysis, ideal for in-clinic diagnostic procedures. In contrast, the AT-Patch is a wearable ECG monitor designed for continuous, long-term ambulatory monitoring to detect arrhythmias and electrical abnormalities.

Choose Aplio i900 if…

Choose the Aplio i900 if your clinical practice requires a premium, on-premise cardiovascular ultrasound system for real-time, in-depth structural and functional cardiac assessment. It is ideal for complex diagnostics, interventional planning, and situations demanding advanced 4D imaging, AI-powered analysis, and precise measurements of cardiac mechanics.

View Aplio i900 →

Choose AT-Patch (ATP-C130/ATP-C70) if…

Choose the AT-Patch if you need a convenient, wearable solution for long-term continuous ambulatory ECG monitoring to detect intermittent arrhythmias. This device is best suited for patients requiring up to 14 days of monitoring in an outpatient setting, offering comfort, shower-proof design, and integrated AI for efficient arrhythmia detection and analysis.

View AT-Patch (ATP-C130/ATP-C70) →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Aplio i900 AT-Patch (ATP-C130/ATP-C70)
Pricing Varies N/a
Deployment Mobile, compact diagnostic ultrasound system Wearable device for patients; analysis software deployed on-premise at medical institutions.
BAA Available Yes AI-estimated Unknown
FDA Status Yes AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Aplio i900

Tool A emphasizes 'Intuitive Ergonomics' and 'Touch-control Screens' for the clinician, along with 'Real-time Quick Scan for Automatic Image Adjustments,' directly enhancing the user experience for operating a complex diagnostic system. While Tool B focuses on patient comfort and ease of use for the wearable, Tool A's features are more directly related to the usability of the AI-powered diagnostic tool for the healthcare professional.

Clinical Value

Aplio i900

Tool A, a 'Premium Cardiovascular Ultrasound System,' offers advanced 4D imaging, deep learning AI for image enhancement, and automated analysis for a wide range of cardiac parameters, providing comprehensive and precise diagnostic capabilities. While Tool B offers valuable continuous ECG monitoring for arrhythmia detection, Tool A's breadth and depth of diagnostic information for complex cardiac conditions suggest a higher overall clinical impact.

Pricing & Value

Tie

Both tools explicitly state that their pricing is not publicly available and requires direct contact with the vendor or distributors. Without any transparent pricing information or comparative cost-benefit analyses, it is impossible to objectively determine which tool offers better value.

Enterprise Readiness

Aplio i900

Tool A is an on-premise console ultrasound system, representing a well-established model for integration into existing hospital imaging departments and IT infrastructure. It is FDA cleared and HIPAA compliant. Tool B, while also FDA cleared and likely HIPAA compliant, involves a wearable device program that may require additional operational workflows for device distribution, collection, and management within an enterprise setting.

Innovation

AT-Patch (ATP-C130/ATP-C70)

Tool B demonstrates significant innovation in patient-centric remote monitoring, offering up to 14 days of continuous ECG monitoring with a compact, lightweight, and shower-proof design, integrated with AI for arrhythmia detection. This approach to extended, comfortable, and robust wearable cardiac monitoring represents a more disruptive advancement in patient care compared to Tool A's AI enhancements for existing high-end imaging capabilities.

Support & Docs

Aplio i900

As a product of Canon Medical Systems Corporation, a large, established global manufacturer of complex medical imaging equipment, Tool A is backed by extensive resources for technical support, field service, training, and comprehensive documentation. While Tool B's company, ATsens Co., also provides support, the scale and global reach of Canon Medical Systems suggest a more robust and comprehensive support infrastructure.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Aplio i900 AT-Patch (ATP-C130/ATP-C70)
Name Aplio i900 AT-Patch (ATP-C130/ATP-C70)
Company Canon Medical Systems Corporation ATsens Co.
Description The Aplio i900 is a premium cardiovascular diagnostic ultrasound system by Canon Medical Systems, featuring advanced 4D imaging, AI-powered image enhancement, and automated analysis tools for precise and efficient cardiac diagnostics. AT-Patch by ATsens Co. is an FDA-cleared wearable ECG monitor offering up to 14 days of continuous cardiac monitoring with high accuracy, a shower-proof design, and integrated AI-powered analysis software for enhanced arrhythmia detection.
Key Features Premium Cardiovascular Ultrasound System, Advanced 4D Imaging (e.g., 4D TEE, MVA), Automated Analysis & Measurement Tools (EF, GLS, MPI, 3D Wall Motion Tracking), iPerformance (Extreme Processing Power), iSense & Touch-control Screens for Intuitive Ergonomics, Real-time Quick Scan for Automatic Image Adjustments, 3rd Harmonic Imaging (3-HI) with Deep Learning AI, SMI Angio (Superb Micro-vascular Imaging) for Microvascular Flow Up to 14 days of continuous ECG monitoring (ATP-C130), High-performance sensor chip for accurate ECG signal acquisition, Short-length electrode to minimize motion artifact noise, Shower-proof design (IP57 for ATP-C130, IP44 for ATP-C70), No charging or electrode replacement required during monitoring, Compact and lightweight (13g) for patient comfort, AT-Note smartphone app for live ECG viewing and symptom recording, AT-Report software with AI/machine learning algorithms for ECG analysis
Categories Cardiology AI, Radiology & Imaging AI Cardiology AI, Wearables & Remote Monitoring (RPM)

Videos

Demos, reviews, and walkthroughs featuring Aplio i900 and AT-Patch (ATP-C130/ATP-C70).

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

The Aplio i900 is a premium cardiovascular diagnostic ultrasound system used for advanced 4D imaging and automated analysis in cardiac diagnostics, including 4D TEE and Mitral Valve Analysis (MVA). The AT-Patch is a wearable ECG monitor designed for up to 14 days of continuous cardiac monitoring and AI-powered arrhythmia detection.
The Aplio i900 features AI-powered image enhancement, automated analysis and measurement tools for parameters like Ejection Fraction (EF), Global Longitudinal Strain (GLS), Myocardial Performance Index (MPI), and 3D Wall Motion Tracking, and Deep Learning AI for 3rd Harmonic Imaging. The AT-Patch integrates AI/machine learning algorithms within its AT-Report software for enhanced ECG analysis and arrhythmia detection.
The Aplio i900 provides real-time diagnostic imaging and analysis during a clinical examination. The AT-Patch offers continuous ECG monitoring for an extended period, up to 14 days, with its ATP-C130 model.
The Aplio i900 is a premium cardiovascular ultrasound system primarily designed for Cardiology and Radiology specialties. The AT-Patch, an ambulatory ECG monitor, is intended for use across Cardiology, Family Medicine, and Internal Medicine.
AI Tool Finder
AI-powered search. Results may not be comprehensive.